Q2 Gold Demand Rose On Strong ETF Inflows, Says World Gold Council
Including over-the-counter (OTC) investment, total bullion demand rose 3% year on year between April and June, to 1,249 tonnes.
In value terms, demand soared 45% to $132 billion, thanks to fresh gold price strength. The precious metal printed a new quarterly record of $3,280.35 per ounce, the WGC said. This was up 40% year on year and 15% from quarter one.
Gold prices struck new all-time highs just above $3,500 per ounce in late April.
Gold ETFs Lead Investment Flows
Robust ETF inflows, combined with strong bar and coin demand, drove total gold investment demand 78% higher year on year, the WGC said. This totalled a whopping 477 tonnes.
The Council said that 'the themes that created such fertile ground for gold investment in Q1 remained very much in play during the second quarter.'
These included 'fluctuating US trade policy; a weaker US dollar; heightened geopolitical tensions punctuated by regional flare-ups; close attention to the respective paths of inflation and economic growth; and fresh record highs in the gold price that attracted further investment inflows,' it added.
Gold-backed ETFs saw a 170-tonne increase in quarterly holdings, as strong demand in April and June offset May's monthly decline.
As a result, total holdings rose 397 tonnes over the course of the first half. This represented the strongest semi-annual performance since the first half of 2020, when funds printed a record 734-tonne increase.
North American ETFs added 73 tonnes of the yellow metal, taking total holdings to 1,857 tonnes (and assets under management (AUMs) to $196 billion).
Asian inflows were slightly behind at 70 tonnes. The WGC described buying activity as 'all the more impressive considering their collective holdings are less than one-fifth the size at 321 tonnes ($35 billion).'
European funds added 24 tonnes, taking physical holdings to 1,367 tonnes and AUMs to $144 billion.
Mixed Demand Elsewhere
Elsewhere, second-quarter gold bar and coin demand was up 11% year on year, at 307 tonnes.
This was down 6% from the 'very strong' 325 tonnes punched in the prior quarter, the WGC said. However, it added that quarter two's investment was 'comfortably above the 290-tonne five-year quarterly average.'
Solid second-quarter demand also meant first-half bar and coin investment reached levels not seen since 2013.
Central banks bought 167 tonnes of the precious metal, though this was down 21% year on year and 33% on a quarterly basis.
The WGC said that 'this represents the lowest level of quarterly demand since quarter two of 2022.' But it added that 'demand remains 41% above the average quarterly level that was typical between 2010 and 2021.'
Gold jewellery demand totalled 341 tonnes, down 14% year on year. The Council said that 'volumes continued to decline… as record gold prices during the quarter further impinged on affordability.'
Jewellery demand fell to levels not seen since the third quarter of 2020.
Technological demand for gold slipped 2% year on year to 78.6 tonnes, as tariff-related uncertainty impacted the electronics industry.
On the supply side, levels rose 3% year on year in the second quarter, to 1,249 tonnes. Mine production edged 1% higher, to 909 tonnes. Recycled gold volumes increased 4% to 347 tonnes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
1 Magnificent S&P 500 Dividend Stock Down 4% to Buy and Hold Forever
Key Points Coca-Cola and the S&P 500 have moved in opposite directions over the last three months. Revenue rose due to higher prices. The company has raised its dividend annually for more than six decades. 10 stocks we like better than Coca-Cola › The market has rebounded impressively after a rough few months at the start of the year. Over the last three months, through July 29, the S&P 500 index has gained 14.6%. However, Coca-Cola's (NYSE: KO) share price has moved in the opposite direction, losing 4.1%. That may scare some people, but dividend-seeking investors should view this as a buying opportunity. In fact, Coca-Cola should be part of their core long-term holdings. Higher revenue Coca-Cola only sells beverages. That means management can concentrate its efforts solely on this business and not get distracted by unrelated or tangential businesses. While it's known for soda, it also sells other drinks like water, juice, sports drinks, and plant-based beverages. That's beneficial given consumers' changing tastes. Right now, people have been more drawn to healthier drinks. The company sells its products globally in more than 200 countries. This geographic reach helps diversify Coca-Cola's revenue stream. Nonetheless, investors were undoubtedly disappointed by Coca-Cola's second-quarter revenue. While volume had been positive, it dropped in the second quarter. Revenue, removing foreign-currency translation effects and the impact from acquisitions/divestitures, grew 5% from a year ago. This was entirely due to higher prices and a different mix, which added 6 percentage points. Decreased volume subtracted 1 percentage point. Still, it's heartening to see Coca-Cola grow profits even in a challenging quarter. Adjusted operating income increased 15% year over year. While consumers may have gotten tired of overall price increases, when they adjust, they'll undoubtedly buy more Coca-Cola products. They're popular and ubiquitous -- you can find the items in stores, restaurants, and stadiums, among other places. Dividend grower Fortunately, Coca-Cola investors can rely on collecting dividends. You can see the company's strong commitment by looking at its history. The board of directors raised the quarterly payout by more than 5% this year to $0.51. That marked an impressive 63 straight years of higher dividends, and makes the company a Dividend King. Even more importantly, Coca-Cola has the ability to keep making payouts. It has a 69% payout ratio, which indicates the company can easily afford to keep paying dividends out of its earnings. The stock has a higher dividend yield than the large-cap stocks as measured by the S&P 500. Coca-Cola shares yield 3% compared to 1.2% for the index. Better valuation Meanwhile, the share price drop over the last three months has resulted in a better valuation. Coca-Cola's price-to-earnings (P/E) ratio currently stands at 24, down from 29. The stock also has a better valuation than the S&P 500. The index has a P/E multiple of 30. Formed in 1886, Coca-Cola is a mature company, so it may never achieve breakneck sales and earnings growth. Its own long-term goals call for 4% to 6% annual revenue growth and 7% to 9% earnings per share increases. But if you're looking for steady gains that produce stock price appreciation and dividends, Coca-Cola belongs in your portfolio. And with the recent stock price dip, the shares trade at a more attractive valuation. That adds up to a buying opportunity for long-term investors looking for an attractive total return opportunity. Should you invest $1,000 in Coca-Cola right now? Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Coca-Cola wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Lawrence Rothman, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. 1 Magnificent S&P 500 Dividend Stock Down 4% to Buy and Hold Forever was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
What UK investors can learn from Warren Buffett's recent trades
Warren Buffett's every move is analysed under a microscope — and with good reason. As the driving force behind Berkshire Hathaway, he's created one of the most successful investment records in history. But what does his latest trading activity reveal? And are there lessons here for UK investors? While Buffett doesn't typically invest in UK-listed companies, many shares on the FTSE 100 have similar characteristics to those in his portfolio — global reach, pricing power, and consistent cash generation. In particular, two recent Berkshire Holdings — Johnson & Johnson and Constellation Brands — remind me of UK equivalents AstraZeneca and Unilever (LSE: ULVR). Here's why they may be worth considering for UK investors. A defensive pharma pick Buffett trimmed his position in healthcare giant J&J a few years ago but the logic behind owning large-cap pharma remains. Companies like these benefit from wide moats, high barriers to entry, and products people rely on regardless of the economic cycle. In that sense, AstraZeneca fits the bill. The firm has built a diverse drug portfolio and is investing in oncology, immunology, and rare diseases treatments. It also boasts impressive financials: revenue grew 12% in the second quarter of 2025 and earnings per share climbed 27%. Although the dividend yield is a modest 2.2%, the payout ratio is well-covered by earnings and has room to grow. The price-to-earnings (P/E) ratio of 19.7 may look high at first glance, but is arguably justified by the company's strong pipeline of long-term growth potential. One risk? Drug development failures and regulatory hurdles can hit revenue and sentiment hard — but for investors seeking Buffett-style defensiveness, AstraZeneca is one to consider. Always in demand Buffett has been increasing Berkshire's position in Constellation Brands recently. His love for well-known branded consumer products stems from their pricing power, consistency, and brand loyalty — traits also found in UK consumer goods giant Unilever. With household names like Dove, Hellmann's, and Persil in its portfolio, Unilever enjoys broad global exposure. In Q2 2025, turnover rose 3.3% year on year, driven by a return to volume growth. Despite inflationary pressure, it maintained operating margins above 16% — impressive for a company in this space. The 3.4 % dividend yield, backed by a payout ratio of around 75%, offers solid passive income potential. And while the share price has struggled in recent years, a forward P/E ratio of 17 suggests the worst may already be priced in. The current competitive landscape is challenging, though, and poses risks to Unilever's bottom line. Changing consumer tastes and competition from private labels could continue to weigh on profits. Over an extended period, this could threaten a dividend cut if debt piles up. Still, when looking at the bigger picture, I believe the scale and brand power of the company are enough to keep it resilient. Sustainable quality Buffett's investment principles — buy quality, hold long, ignore the noise – continue to resonate. While Berkshire Hathaway may not be snapping up FTSE 100 stocks, businesses like AstraZeneca and Unilever share many of the same strengths as his US holdings. For patient UK investors, following his philosophy might just pay off. The post What UK investors can learn from Warren Buffett's recent trades appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Mark Hartley has positions in AstraZeneca Plc and Unilever. The Motley Fool UK has recommended AstraZeneca Plc, Constellation Brands, and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
RC365 Holding Reports Full Year 2025 Earnings
RC365 Holding (LON:RCGH) Full Year 2025 Results Key Financial Results Revenue: HK$14.1m (down 36% from FY 2024). Net loss: HK$30.8m (loss narrowed by 17% from FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period RC365 Holding's share price is broadly unchanged from a week ago. Risk Analysis Be aware that RC365 Holding is showing 4 warning signs in our investment analysis and 2 of those are significant... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
